“Re-branding” a disease: From NAFLD to MAFLD

Researchers believe that a re-classification of NAFLD, which affects nearly a billion people globally with no drug treatment currently on the market, is essential to improve patient understanding and industry funding to better mitigate its impact.

Continue reading

Copyright © 2024 Florida Research Institute. All Rights Reserved.